Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Oct 31, 2025 | (FY)Apr 30, 2025 | (Q6)Oct 31, 2024 | (FY)Apr 30, 2024 | (Q6)Oct 31, 2023 | (FY)Apr 30, 2023 | (Q6)Oct 31, 2022 | (FY)Apr 30, 2022 | (Q6)Oct 31, 2021 | (FY)Apr 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 48.39%-5.89M | ---- | 64.07%-11.41M | ---- | -68.57%-31.75M | ---- | -59.17%-18.83M | ---- | -224.01%-11.83M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 18.70%-200K | ---- | -61.84%-246K | ---- | ---152K | ---- | ---- | ---- | ---- |
| Impairment and provisions: | ---- | -66.77%1.88M | ---- | 37.08%5.65M | ---- | -73.23%4.12M | ---- | 742.47%15.39M | ---- | -13.58%1.83M |
| -Impairment of trade receivables (reversal) | ---- | -66.77%1.88M | ---- | --5.65M | ---- | ---- | ---- | ---242K | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | -73.64%4.12M | ---- | 755.72%15.63M | ---- | -13.58%1.83M |
| Revaluation surplus: | ---- | -100.93%-26K | ---- | -72.72%2.79M | ---- | 2,148.00%10.24M | ---- | 84.63%-500K | ---- | ---3.25M |
| -Other fair value changes | ---- | -100.93%-26K | ---- | -72.72%2.79M | ---- | 2,148.00%10.24M | ---- | 84.63%-500K | ---- | ---3.25M |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | 22.30%-526K | ---- | 18.43%-677K | ---- | -1,506.78%-830K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---526K | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 41.27%-380K | ---- | -1,196.61%-647K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -62.30%-297K | ---- | ---183K |
| Depreciation and amortization: | ---- | ---- | ---- | ---- | ---- | -81.18%16K | ---- | -95.24%85K | ---- | -25.01%1.78M |
| Financial expense | ---- | ---- | ---- | ---- | ---- | 0.00%260K | ---- | -6.14%260K | ---- | -10.06%277K |
| Special items | ---- | ---- | ---- | ---- | ---- | 70,650.00%5.66M | ---- | -99.92%8K | ---- | 980.11%9.94M |
| Operating profit before the change of operating capital | ---- | -31.87%-4.24M | ---- | 73.51%-3.21M | ---- | -184.34%-12.13M | ---- | -103.92%-4.27M | ---- | -198.31%-2.09M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | -133.90%-4.06M | ---- | -44.80%11.97M | ---- | 1,048.69%21.69M | ---- | -111.11%-2.29M | ---- | 153.11%20.58M |
| Accounts payable increase (decrease) | ---- | -125.67%-345K | ---- | -56.11%1.34M | ---- | 132.54%3.06M | ---- | 48.89%-9.41M | ---- | -275.47%-18.41M |
| Financial assets at fair value (increase)decrease | ---- | ---1.64M | ---- | ---- | ---- | -13.98%-11.36M | ---- | -41.93%-9.97M | ---- | ---7.02M |
| Special items for working capital changes | ---- | 66.05%-388K | ---- | 42.99%-1.14M | ---- | ---2.01M | ---- | ---- | ---- | -1,225.32%-13.66M |
| Cash from business operations | ---- | -219.04%-10.67M | ---- | 338.14%8.96M | ---- | 85.49%-3.76M | ---- | -25.79%-25.93M | ---- | 24.10%-20.61M |
| Other taxs | ---- | -177.78%-50K | ---- | ---18K | ---- | ---- | ---- | ---- | ---- | -21.68%-2.21M |
| Special items of business | 92.80%-493K | ---- | -456.83%-6.85M | ---- | 77.10%-1.23M | ---- | 40.77%-5.37M | --17.18M | 50.72%-9.07M | ---- |
| Net cash from operations | 92.80%-493K | -219.84%-10.72M | -456.83%-6.85M | 337.67%8.94M | 77.10%-1.23M | 57.00%-3.76M | 40.77%-5.37M | 61.66%-8.75M | 50.72%-9.07M | 21.23%-22.82M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | --52K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -69.26%380K | ---- | 930.00%1.24M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | --876K | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | --3.25M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---7.25M | ---- | ---- | ---- | ---- |
| Other items in the investment business | ---- | ---- | --3.31M | ---- | ---- | ---- | ---- | ---- | -348.92%-921K | ---- |
| Net cash from investment operations | ---- | --3.3M | --3.31M | ---- | ---- | -1,777.37%-6.37M | ---- | -69.26%380K | -348.92%-921K | 1,033.94%1.24M |
| Net cash before financing | 86.07%-493K | -182.91%-7.41M | -187.64%-3.54M | 188.21%8.94M | 77.10%-1.23M | -21.13%-10.14M | 46.23%-5.37M | 61.23%-8.37M | 44.60%-9.99M | 25.22%-21.58M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --18K |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | -1.14%1.74M | ---- | -82.57%1.76M | ---- | --10.08M |
| Interest paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 64.58%-17K |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---226K |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | --1.15M | ---- | ---- | ---- |
| Net cash from financing operations | ---- | ---- | ---- | ---- | ---- | -1.14%1.74M | --1.15M | -81.06%1.76M | ---- | 1,215.26%9.28M |
| Net Cash | 86.07%-493K | -182.91%-7.41M | -187.64%-3.54M | 206.45%8.94M | 70.85%-1.23M | -27.05%-8.4M | 57.76%-4.22M | 46.26%-6.61M | 32.15%-9.99M | 58.57%-12.3M |
| Begining period cash | -70.69%3.07M | 578.33%10.49M | 578.33%10.49M | -84.45%1.55M | -84.45%1.55M | -39.93%9.95M | -39.93%9.95M | -42.63%16.56M | -42.63%16.56M | -50.71%28.86M |
| Cash at the end | -62.86%2.58M | -70.69%3.07M | 2,099.05%6.95M | 578.33%10.49M | -94.48%316K | -84.45%1.55M | -12.81%5.73M | -39.93%9.95M | -53.54%6.57M | -42.63%16.56M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. | -- | PRIVATCO CPA LIMITED | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.